Dr. Hindu Rao

Assistant Professor; Clinical Faculty

Pharmacy, School of Pharmacy

Expertise: Chronic Disease Management; Diabetes Mellitus; Hypertension; Population Health; Ambulatory Care

Media Contact »

Office Location: 9401 275

Phone: (714) 516-5535

Email: hrao@chapman.edu

Biography

Dr. Hindu Rao received her Bachelor of Science in Pharmacological Chemistry from the University of California San Diego (UCSD) and her Doctor of Pharmacy at the University of California San Francisco (UCSF) School of Pharmacy. At UCSF, she received recognition for demonstrating outstanding leadership service and contributing to the pharmacy teaching program. She was also involved in multiple research projects studying the effectiveness of pharmacist-led work on health outcomes and was initiated as a member of the Rho Chi Society, an academic honor society in pharmacy.

Dr. Rao completed her pharmacy practice residency (PGY-1) training at Cedars Sinai Medical Network and Chapman University School of Pharmacy (CUSP), with a focus in ambulatory care practice. Throughout her residency training, she was involved in teaching CUSP students in the classroom and in ambulatory care clinics and received the Resident Teacher of the Year award.

In addition to her current role as Clinical Assistant Professor of Pharmacy Practice at CUSP, Dr. Rao practices as an ambulatory are pharmacist at Providence Medical Foundation. She focuses on chronic disease and medication management, particularly cardiovascular risk reduction, and precepts pharmacy students during experiential rotations at her practice site.

Research Interests:

Dr. Rao's research interests include using telemedicine and digital health tools to strengthen primary care, implementing ambulatory care pharmacy services, evaluating the impact of pharmacist‑led interventions in primary care settings, and fostering communication skills among pharmacy students.

Recent Creative, Scholarly Work and Publications: Mikhail M, Rao H. The Student Perspective on Chat-Based AI Tools. AACP Pharmacy Practice Section Winter Newsletter. January 2024. bit.ly/AACPPharmPracNewsWinter24; Rao H, Beuttler R, Dintzner M, Taheri R, Bach A, Fakourfar N*. Impact of a Feedback Strategy in a Series of Communication-Focused Patient Care Simulations. Journal of the American College of Clinical Pharmacy. May 2024;1-7. https://doi.org/10.1002/jac5.1959; Bach A, Bethishou L, Beuttler R, Fakourfar N, Rao H. Comparison of Virtual Simulations with Peers versus Actors as Standardized Patients on Virtual OSCE Scores. American Journal of Pharmaceutical Education. March 2023;87(5). https://doi.org/10.1016/j.ajpe.2022.11.004; Fakourfar N, Rao H. Pharmacy Student Involvement in Population Health Management of Statin Quality Measures. Journal of the American College of Clinical Pharmacy. February 2023;1-7. https://doi.org/10.1002/jac5.1769; Lyon K, Rao H. Learn the Lingo: Consumer Assessment of Healthcare Providers and Systems (CAHPS). APhA-APPM Medical Home/ACO SIG forum. March 2023. https://www.pharmacist.com/Practice/Practice-Resources/Learn-the-Lingo/consumer-assessment- of-healthcare-providers-and-systems-cahps; Rao H, Fakourfar N. Pharmacy Student Leadership in Experiential Education. AACP Experiential Education Section Newsletter. May 2022.; Lau R, Rao H. Learn the Lingo: Federally Qualified Health Center (FQHC). APhA-APPM Medical Home/ACO SIG forum. March 2022. https://www.pharmacist.com/Practice/Practice-Resources/Learn-the-Lingo/federally-qualified-health-center-fqhc; Kelly M, Lewis J, Rao H, Carter J, Portillo I, Beuttler R. Effects of GLP-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta-analysis. Pharmacotherapy. December 2022;42(12):921-928. https://pubmed.ncbi.nlm.nih.gov/36271706/; Lowe C, Johnson A, Rao H, Walsh A, Tsu L. Emerging Evidence for the Use of SGLT2 Inhibitors in Heart Failure Management. Journal of Contemporary Pharmacy Practice. March 2022;69(1):32–34. https://meridian.allenpress.com/jcphp/article/69/1/32/479709/Emerging- Evidence-for-the-Use-of-SGLT2-Inhibitors; Rao H, Eclevia M, Phan P, Tsu L. Geriatric Pharmacotherapy Case Series: Antiplatelet Therapy in Older Patients Post Myocardial Infarction. Sr Care Pharm. January 2022;37(1): 17-23. doi: 10.4140/TCP.n.2022.17. https://pubmed.ncbi.nlm.nih.gov/34953509/; Rao H, Fakourfar N, Sun C, Lewis J. The Use of Continuous Glucose Monitoring in Older People With Type 2 Diabetes. Sr Care Pharm. November 2021;36(11):556-567. doi: 10.4140/TCP.n.2021.556. https://pubmed.ncbi.nlm.nih.gov/34717787/; Rao H, Learn the Lingo: Case Management / Care Coordination. APhA-APPM Medical Home/ACO SIG forum. February 2021. https://pharmacist.com/Practice/Practice-Resources/Learn-the-Lingo/case-managementcare-coordination; Sun C, Venrick B, Rao H, Tsu L. Antithrombotic Therapy in Patients with Valvular Heart Disease. U.S. Pharm. February 2021;46(2):21-24.; Rao H, Fakourfar N. Virtual Patient Care Simulations Are Here to Stay. AACP Communications Committee Summer Newsletter. June 2021.; Rao H, Learn the Lingo: Population Health. APhA-APPM Medical Home/ACO SIG forum. January 2020. https://pharmacist.com/Practice/Practice-Resources/Learn-the-Lingo/population-health; Rao H, Lewis J. Does Long-Term Proton Pump Inhibitor Use Pump Up Your Risk of Adverse Effects iForumRx. May 2020. https://iforumrx.org/commentary/does-long-term-proton-pump-inhibitor-use-pump-your-risk-adverse-effects

Dr. Hindu Rao

Biography

Recent Creative, Scholarly Work and Publications

Faculty Directories by School or College